Matches in Nanopublications for { ?s ?p "DDI between Ritonavir and Doxepin - Ritonavir may increase the effect and toxicity of the tricyclic antidepressant, doxepin, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of doxepin if ritonavir if initiated, discontinued or dose changed. [drugbank_resource:DB00503_DB01142]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00503_DB01142 label "DDI between Ritonavir and Doxepin - Ritonavir may increase the effect and toxicity of the tricyclic antidepressant, doxepin, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of doxepin if ritonavir if initiated, discontinued or dose changed. [drugbank_resource:DB00503_DB01142]" assertion.